- Base Year: 2018
- Estimated Year: 2019
- Forecast Period: 2019 to 2026
The global Whole Exome Sequencing market is expected to increase from USD 1,019 million in 2019 to USD 3,353 million by 2026, registering a CAGR of 18.54% from 2019 to 2026.
Whole exome sequencing is a technology that caused complete DNA sequence of an organism’s genome at a single time through the help of various laboratory processes. In the future of personalized medicine, whole genome sequence will play an important role in guiding the therapeutic intervention. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s disease.
Get FREE Sample of Whole Exome Sequencing Market Report at: https://www.globalmarketmonitor.com/reports/135329-global-whole-exome-sequencing-market-report-2018.html#download-sample
Key players in the Whole Exome Sequencing market cover Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, and others.
Purchase a copy of Whole Exome Sequencing report at: https://www.globalmarketmonitor.com/reports/135329-global-whole-exome-sequencing-market-report-2018.html#report-inquiry
Market Driver and Restraint
Whole Exome Sequencing market has witnessed considerable growth in the recent past, owing to the increasing population along with rising incidences of cancer and other infectious diseases. However, lack of skilled manpower and professionals and dependency on the government authorities for approvals and grants restrain the growth of the Whole Exome Sequencing market.
Forecast by Geography
In 2018, the global Whole Exome Sequencing market was mainly concentrated in the three regions of Asia-Pacific, North America, and Europe. North America is the largest market at a share of 35.48%, owing to advanced technology, sufficient funds available at disposal, and the interest of the government and private organizations in developing this method and making it more cost-effective.
Europe is currently leading Asia-Pacific with a share of 27.54% and 26.98%. It is expected that Asia will grow at a fairly rapid rate in the near future due to the rise in health awareness and demand for advanced medical technology.
- Agilent HaloPlex
- Agilent SureSelect
- Agilent SureSelect QXT
- Illumina TruSeq Exome
- Roche Nimblegen SeqCap
- MYcroarray MYbaits
- Mendelian disease and rare syndrome gene discovery
- The research of complex diseases
- Mouse exome sequencing
Ask for a discount at:
Whole Exome Sequencing manufacturers
Raw material suppliers of Whole Exome Sequencing
Distributors and resellers of Whole Exome Sequencing
Whole Exome Sequencing industry associations
Product managers, Whole Exome Sequencing industry administrator, C-level executives of the industries
Market Research and consulting firms
Research & Clinical Laboratories